Whipplewood Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-17
Closed -$4.98K – 776
2026
Q1
$4.98K Buy
+17
New +$5.59K ﹤0.01% 618
2025
Q3
– Sell
-24
Closed -$9.34K – 566
2025
Q2
$9.34K Buy
24
+13
+118% +$5.23K 0.01% 577
2025
Q1
$10K Sell
11
-13
-54% -$5.22K 0.01% 566
2024
Q4
$8.85K Buy
+24
New +$10K 0.01% 573

Other funds holding ELV

Whipplewood Advisors's ELV Position: Q2 2026 in Review

Whipplewood Advisors sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 17 shares — an estimated $4.98K sold.

Whipplewood Advisors first reported a position in ELV in Q4 2024 and held it in 4 quarters. The position peaked at $10K in Q1 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Whipplewood Advisors reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Whipplewood Advisors sold 17 Elevance Health shares in Q2 2026, an estimated $4.98K.
  • Whipplewood Advisors first reported a position in Elevance Health in Q4 2024 and held it in 4 quarters.
  • Whipplewood Advisors's Elevance Health position peaked at $10K in Q1 2025.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.